Authors
Loading...
Analysis reveals antibacterial activity in new benzimidazo[1,2‐c]quinazolines and indolo[2,3‐b]quinoxalines, suggesting potential as drug candidates.
Lamssane et al. (2025) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: